Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System

DEVICE4 trials

Sponsors

Medtronic Vascular

Conditions

ArteriosclerosisCardiovascular DiseasesCoronary Artery DiseaseIschemic Heart DiseaseStenotic Coronary Lesion

Unknown Phase

RESOLUTE ONYX Post-Approval Study

CompletedNCT03063749

Medtronic VascularCoronary Artery Disease

Start: 2017-03-30End: 2022-08-18Updated: 2023-11-22

RESOLUTE ONYX China RCT Study

Active, not recruitingNCT03466151

Medtronic VascularArteriosclerosis, Cardiovascular Diseases, Coronary Artery Disease +2

Start: 2018-04-12End: 2026-07-31Updated: 2026-04-22

RESOLUTE ONYX China Single Arm Study

Active, not recruitingNCT03471845

Medtronic VascularArteriosclerosis, Cardiovascular Diseases, Coronary Artery Disease +2

Start: 2018-03-30End: 2026-08-30Updated: 2026-04-21

RESOLUTE ONYX Post-Approval Study (Bifurcation Cohort)

CompletedNCT03584464

Medtronic VascularCoronary Artery Disease

Start: 2018-05-14End: 2022-09-28Updated: 2023-11-24